Correlation Between Terns Pharmaceuticals and Alnylam Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Terns Pharmaceuticals and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Alnylam Pharmaceuticals.
Diversification Opportunities for Terns Pharmaceuticals and Alnylam Pharmaceuticals
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Terns and Alnylam is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Alnylam Pharmaceuticals go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Alnylam Pharmaceuticals
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to generate 6.65 times less return on investment than Alnylam Pharmaceuticals. In addition to that, Terns Pharmaceuticals is 1.63 times more volatile than Alnylam Pharmaceuticals. It trades about 0.01 of its total potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.07 per unit of volatility. If you would invest 16,860 in Alnylam Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 10,271 from holding Alnylam Pharmaceuticals or generate 60.92% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Alnylam Pharmaceuticals
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Alnylam Pharmaceuticals |
Terns Pharmaceuticals and Alnylam Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Alnylam Pharmaceuticals
The main advantage of trading using opposite Terns Pharmaceuticals and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
| Alnylam Pharmaceuticals vs. ProQR Therapeutics BV | Alnylam Pharmaceuticals vs. Wave Life Sciences | Alnylam Pharmaceuticals vs. Blueprint Medicines Corp | Alnylam Pharmaceuticals vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |